Sodium-iodide symporter (NIS)-mediated accumulation of [211At]astatide in NIS-transfected human cancer cells

Nuclear Medicine and Biology

Volumn 29, Issue 7, 2002, Pages 729-739

  Carlin, Sean ^a   Mairs, Robert J ^b   Welsh, Phil ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

particles; Astatine 211; Iodine 131; NIS; Radiotherapy; Sodium iodide symporter

Indexed keywords

ASTATINE 211; HALIDE; IODINE 131; RADIOISOTOPE; SODIUM IODIDE SYMPORTER; ASTATINE; COTRANSPORTER; PERCHLORIC ACID; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SODIUM DERIVATIVE; SODIUM PERCHLORATE; THIAMAZOLE;

ALPHA RADIATION; ARTICLE; CANCER CELL; CELL ASSAY; CELL LINE; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG UPTAKE; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; GLIOMA; METABOLISM; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ASTATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; HUMANS; IODINE RADIOISOTOPES; METHIMAZOLE; PERCHLORIC ACID; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SODIUM COMPOUNDS; SYMPORTERS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036790032     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(02)00332-3     Document Type: Article

References (27)

1. Appelman E.H. The oxidation states of Astatine in aqueous solution. J. Am. Chem. Soc. 83:1961;805-807.
2. Asling C.W., Durbin P.W., Johnston M.E., Parrott M.W. Demonstration of the concentration of astatine-211 in the mammary tissue of the rat. Endocrinol. 64:1959;579-585.
3. Beierwaltes W.H. The history of the use of radioactive iodine. Semin. Nucl. Med. 9:1979;151-155.
4. 211At α-particle radiotherapy for undifferentiated thyroid cancer. Acta Radiologica. 376:(suppl):1991;174-175.
5. Carlin S., Cunningham S.H., Boyd M., McCluskey A.G., Mairs R.J. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene effect on clonogenicity in both two- and three-dimensional models . Cancer Gene Ther. 7:2000;1529-1536.
6. Chambard M., Verrier B., Gabrion J., Mauchamp J. Polarisation of thyroid cell culture evidence for the basolateral localisation of the iodine pump and of the thyroid-stimulating hormone receptor-adenyl cyclase complex . J. Cell Biol. 96:1983;1172-1177.
7. Dadachova E., Bouzahzah B., Zuckier L.S., Pestell R.G. Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). Nucl. Med. Biol. 29:2002;13-18.
8. De La Vieja A., Dohan O., Levy O., Carrasco N. Molecular analysis of the sodium/iodide symporter impact on thyroid and extrathyroid pathophysiology . Physiol. Rev. 80:2000;1083-1105.
9. 131I as labels of a monoclonal antibody and F(ab′)2 fragment. Cancer Res. 50:(12):1990;3514-3520.
10. Hall E.J. Radiobiology for the Radiologist. 3rd ed. 1988;161-177 Lippincott, Philadelphia.
11. Hamilton J.G., Soley M.H. A comparison of the metabolism of iodine and of element S5 (EKA iodine). Proc. Natl. Acad. Sci. (USA). 26:1940;483-489.
12. Haynie T.P., Vassilopoulou-Sellin R. How safe for the patient is iodine-131 therapy for differentiated thyroid carcinoma? (Editorial) J. Nucl. Med. 36:1995;27-28.
13. 211At]Astatide accumulation in normal tissues primary evaluation of seven potential compounds . Nucl. Med. Biol. 25:1998;351-357.
14. 211At in a murine intraperitoneal tumour model. Gynecol. Oncol. 57:1995;9-15.
15. - symporter (NIS) recent advances . J. Bioenerg. Biomembr. 30:1998;195-206.
16. 125I-transport in porcine thyroid epithelial cells cultured in bicameral chambers. Nucl. Med. Biol. 28:2001;41-50.
17. Mandell R.B., Mandell L.Z., Link C.J. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res. 59:1999;661-668.
18. 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl. Med. Biol. 28:2001;829-834.
19. - symporters for radioiodide concentrator gene therapy. J. Nucl. Med. 41:2000;1898-1904.
20. Smanik P.A., Liu Q., Furminger T.L. Cloning of the human iodide symporter. Biochem. Biophys. Res. Comm. 226:1996;339-345.
21. Spitzweg C., Joba W., Eisenmenger W., Heufelder A.E. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab. 83:1998;1746-1751.
22. Tazebay U.H., Wapnir I.L., Levy O., Dohan O., Zuckier L.S., et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat. Med. 6:2000;871-878.
23. 211At] astatobenzyl-guanidine further evaluation of a potential therapeutic agent . Int. J. Cancer. 57:1994;908-913.
24. Visser G.M., Diemer E.J. Inorganic astatine chemistry formation of complexes of astatine . Radiochima Acta. 33:1983;145-151.
25. - species . Radiochim. Acta. 47:1989;97-103.
26. Weiss S.J., Philp N.J., Grollman E.F. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinol. 114:1984;1090-1098.
27. Zalutsky M.R., Vaidyanathan G. Astatine-211-labelled radiotherapeutics, An emerging approach to targeted alpha-particle radiotherapy. Curr. Pharmaceutical. Des. 6:2000;1433-1455.